In The News
Class closure ‘anathema’ to class action regime, contradictors tell High Court
Class action over COVID-19 deaths settles with Anglicare, NSW Health
MinRes boss Chris Ellison to step down after disclosure, integrity failures
Carnival settles class action over ‘cruise from hell’
Escala’s non-compete restraints against ex-partners an ‘overreach’: court
X appeals eSafety’s win over child exploitation notice
‘Deliberate defiance’: Lawyer who practiced after certificate nixed struck from roll
Jones Day recruits tax partner from Baker McKenzie
Judge’s ‘uncritical copying and pasting’ of submissions wins the day for law firm
Pauline Hanson’s tweet ‘a strong form of racism’, court finds
Please login to bookmarkClose

Merck Sharp & Dohme has filed a lawsuit accusing rival drug company Bristol-Myers Squibb of misusing its market power by restricting access to a treatment program for stage IV melanoma patients.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au